MediXall (MDXL) Shares Outstanding (Weighted Average) (2019 - 2024)
MediXall's Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $145.1 million for Q3 2024.
- For Q3 2024, Shares Outstanding (Weighted Average) rose 11.21% year-over-year to $145.1 million; the TTM value through Sep 2024 reached $145.1 million, up 11.21%, while the annual FY2023 figure was $127.2 million, 9.0% up from the prior year.
- Shares Outstanding (Weighted Average) reached $145.1 million in Q3 2024 per MDXL's latest filing, up from $136.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $145.1 million in Q3 2024 to a low of -$0.01 in Q1 2021.
- Average Shares Outstanding (Weighted Average) over 5 years is $108.1 million, with a median of $115.4 million recorded in 2022.
- Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 100.0% in 2021, then skyrocketed 1146258090100.0% in 2022.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $90.6 million in 2020, then increased by 14.98% to $104.2 million in 2021, then increased by 11.96% to $116.7 million in 2022, then grew by 9.0% to $127.2 million in 2023, then rose by 14.11% to $145.1 million in 2024.
- Per Business Quant, the three most recent readings for MDXL's Shares Outstanding (Weighted Average) are $145.1 million (Q3 2024), $136.4 million (Q2 2024), and $134.0 million (Q1 2024).